APA (7th ed.) Citation

Guerra, A., Costantino, C., Martinon-Torres, F., Westerholt, S., Lambeth, C., Chen, Z., . . . Wilck, M. A phase 4, open-label study to evaluate the safety and immunogenicity of DTaP5-HBV-IPV-Hib in children previously vaccinated with DTaP2-HBV-IPV-Hib or DTaP5-HBV-IPV-Hib (V419-016). Taylor & Francis Group.

Chicago Style (17th ed.) Citation

Guerra, Andrea, et al. A Phase 4, Open-label Study to Evaluate the Safety and Immunogenicity of DTaP5-HBV-IPV-Hib in Children Previously Vaccinated with DTaP2-HBV-IPV-Hib or DTaP5-HBV-IPV-Hib (V419-016). Taylor & Francis Group.

MLA (9th ed.) Citation

Guerra, Andrea, et al. A Phase 4, Open-label Study to Evaluate the Safety and Immunogenicity of DTaP5-HBV-IPV-Hib in Children Previously Vaccinated with DTaP2-HBV-IPV-Hib or DTaP5-HBV-IPV-Hib (V419-016). Taylor & Francis Group.